Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,778 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial.
Song Y, Tilly H, Rai S, Zhang H, Jin J, Goto H, Terui Y, Shin HJ, Kim WS, Cao J, Feng J, Eom HS, Kim TM, Tsai XC, Gau JP, Koh H, Zhang L, Song Y, Yang Y, Li W, Huang H, Ando K, Sharman JP, Sehn LH, Bu L, Wang X, Jiang Y, Hirata J, Lee C, Zhu J, Izutsu K. Song Y, et al. Among authors: kim tm, kim ws. Blood. 2023 Apr 20;141(16):1971-1981. doi: 10.1182/blood.2022017734. Blood. 2023. PMID: 36626583 Free PMC article. Clinical Trial.
Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: pharmacokinetics and recommended phase 2 dose.
Venkatakrishnan K, Kim TM, Lin CC, Thye LS, Chng WJ, Ma B, Chen MH, Zhou X, Liu H, Kelly V, Kim WS. Venkatakrishnan K, et al. Among authors: kim tm, kim ws. Invest New Drugs. 2015 Aug;33(4):942-53. doi: 10.1007/s10637-015-0258-y. Epub 2015 Jun 19. Invest New Drugs. 2015. PMID: 26084989 Clinical Trial.
Psychometric validation of the short version of the Information Needs in Cardiac Rehabilitation scale through a first global assessment.
Ghisi GLM, Cruz MMAD, Vanderlei LCM, Liu X, Xu Z, Jiandani MP, Cuenza L, Kouidi E, Giallauria F, Mohammed J, Maskhulia L, Trevizan PF, Batalik L, Pereira DG, Tourkmani N, Burazor I, Venturini E, Lira GG, Rehfeld MBCV, Neves VR, Borges GJ, Kim WS, Cha S, Zhang L, Grace SL. Ghisi GLM, et al. Among authors: kim ws. Eur J Prev Cardiol. 2024 May 9:zwae148. doi: 10.1093/eurjpc/zwae148. Online ahead of print. Eur J Prev Cardiol. 2024. PMID: 38722027
ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study.
Maris M, Salles G, Kim WS, Kim TM, Lyons RM, Arellano M, Karmali R, Schiller G, Cull E, Abboud CN, Batlevi C, Kagiampakis I, Rebelatto MC, Lee Y, Kirby LC, Wang F, Bothos J, Townsley DM, Fathi AT, Ribrag V. Maris M, et al. Among authors: kim ws. Target Oncol. 2024 Apr 29. doi: 10.1007/s11523-024-01054-z. Online ahead of print. Target Oncol. 2024. PMID: 38683495
2,778 results